Latest AI Startup Funding Rounds
Funding for companies building AI models, tools and applications. Explore the products, customers and businesses attracting capital.
- Rounds
- 2,480 Jan 1 – Oct 27, 2026
- Disclosed funding
- $249.2B 2056 disclosed amounts
- Median round
- $15M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| UA Upscale AICompany profile Provides open-standard AI networking infrastructure for ultra-low-latency training and inference Provides open-standard AI networking infrastructure for ultra-low-latency training and inference | $190M | Series A+Series A | AI, Hardware | United States | Investors | |
| B BasetenCompany profile Builds systems software for AI applications, powering inference and multi-model strategies Builds systems software for AI applications, powering inference and multi-model strategies | $1.5B | Series FSeries C+ | AI | United States | Investors | |
| G GroqCompany profile Operates AI inference cloud infrastructure serving developers and enterprises using LPU chip technology Operates AI inference cloud infrastructure serving developers and enterprises using LPU chip technology | $650M | Growth | AI | United States | Investors | |
| PA Prosper AICompany profile Automates the patient journey from scheduling and insurance to billing and collections Automates the patient journey from scheduling and insurance to billing and collections | $30M | Series A | AI, Healthtech | United States | Investors | |
| NI Nearfield InstrumentsCompany profile Develops advanced 3D scanning probe metrology and inspection systems for semiconductor manufacturing Develops advanced 3D scanning probe metrology and inspection systems for semiconductor manufacturing | $380M | Series DSeries C+ | AI, Hardware | Netherlands | Investors | |
| GT Graph TherapeuticsCompany profile Develops precision medicines for inflammatory and immune-mediated diseases using AI-powered patient cell analysis Develops precision medicines for inflammatory and immune-mediated diseases using AI-powered patient cell analysis | $5M | Series A | AI, Biotech | Austria | Investors | |
| CB ChemT BiotechnologyCompany profile Develops AI virtual cell platform to optimize biomanufacturing processes for biopharma companies Develops AI virtual cell platform to optimize biomanufacturing processes for biopharma companies | $4M | Seed | AI, Biotech | Singapore | Investors | |
 ApexCompany profile Apex manufactures configurable satellite platforms and provides mission services for commercial and national-security space programs. Apex manufactures configurable satellite platforms and provides mission services for commercial and national-security space programs. | >$200M | Series ESeries C+ | AI, Space tech | United States | Investors | |
| V AI-powered operating system for fitness businesses | $1M | Seed | AI, Healthtech | Singapore | Investors | |
| O OneSoilCompany profile Builds satellite-based precision agriculture platform with AI assistant for field monitoring and crop management Builds satellite-based precision agriculture platform with AI assistant for field monitoring and crop management | €1M | Seed+Seed | AI, Agritech | Switzerland | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
111rounds2led - 2General Catalyst
Hyperbolic, 22one, Provision Labs
83rounds6led - 3Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
80rounds15led - 4Lightspeed
Warp Sciences, Different, Zenzap
66rounds7led - 5Accel
Simplismart, Legora, Arda Industries
56rounds7led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.